Cytokinetics | CYTK - Debt


Cytokinetics reported $1.29B in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Acadia Pharmaceuticals USD 50.79M 1.39M Mar/2026
Amgen USD 57.32B 2.72B Mar/2026
Arca Biopharma USD 0 0 Mar/2025
Bayer EUR 36.45B 2.93B Dec/2025
Biogen USD 8.09B 1.53B Jun/2026
Brainstorm Cell Therapeutics USD 1.2M 1.2M Mar/2025
Bristol-Myers Squibb USD 46.43B 711M Mar/2026
Capricor Therapeutics USD 3.38M 0 Mar/2025
Cytokinetics USD 1.29B 4.48M Mar/2026
Eisai JPY 186.08B 50.58B Mar/2026
Eli Lilly USD 43.37B 867M Mar/2026
Exelixis USD 165.93M 3.61M Jun/2026
Geron USD 122.07M 74K Mar/2026
Halozyme Therapeutics USD 2.14B 2.01M Mar/2026
Ionis Pharmaceuticals USD 1.91B 425.5M Jun/2026
Ligand Pharmaceuticals USD 451.98M 486K Mar/2026
Merck USD 49.12B 222M Mar/2026
Novartis USD 49.01B 2.02B Jun/2026
Pfizer USD 63.19B 536M Jun/2026
Regeneron Pharmaceuticals USD 2.71B 400K Jun/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 23.58B 3.56B Jun/2026